Obsidian Therapeutics
The role leads oversight of viral vector and ancillary material production across CDMO partners, establishing a manufacturing specialist function for deviation management, change control, and continuous improvement. It involves managing the manufacturing value stream, ensuring operational readiness, and collaborating with cross‑functional teams to support the development of autologous cell therapy programs.
Headquarters
Cambridge, Massachusetts, United States
Obsidian Therapeutics is a clinical-stage biotechnology company using its proprietary cytoDRiVE® platform to engineer novel TIL (tumor-infiltrating lymphocyte) cell therapies. The platform leverages drug-responsive domains (DRDs) to regulate protein function using an FDA-approved small-molecule drug. The company's lead program, OBX-115 (amsoki-cel), is being evaluated in advanced melanoma in a Phase 1/2 clinical trial.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Obsidian Therapeutics.
4% above the average for this role
Manufacturing Project Specialist
Lonza
Director of Vector Engineering and Manufacturing Quality - Cell Therapy
Marriott International
Sr. Manufacturing Associate – Upstream
avidbio
Director, External Manufacturing - Viral Vectors
AstraZeneca
Director, External Manufacturing, Viral Vector Technical Lead
AstraZeneca
Quality Specialist III
Precision BioSciences